CRDF
CRDF
NASDAQ · Biotechnology

Cardiff Oncology Inc

$1.67
-0.06 (-3.47%)
As of May 16, 9:40 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +547.3% upside
Low Target $7.63
Average Target $10.81
High Target $13.89
Current Price $1.67
Current
$1.67
Target
$10.81
$7.63 $10.81 avg $13.89
Scenario Analysis
Bear Case
$7.63
356.9%
Low target
Base Case
$10.81
+547.3%
Avg target
Bull Case
$13.89
+731.7%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$4.56
-63.3% from high
52-Week Low
$1.48
+12.8% from low
Target vs 52W High
$10.81
+137.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%